Top pre-market gainer +12.72%: NEXUSSURGL.BO Nexus Surgical BSE Feb 2026: INR 22
NEXUSSURGL.BO stock surged 12.72% in pre-market trade, hitting INR 19.85 on Feb 2026 as volumes rose above the five-day average. The jump followed a strong open at INR 17.33 and intra-day high near INR 19.99. Investors should note the stock sits close to its year high of INR 22.00 and trades with a price-to-earnings near 19.20. We summarise drivers, valuation, technicals, and Meyka AI model projections for Nexus Surgical & Medicare Ltd. on BSE.
NEXUSSURGL.BO stock: pre-market move and immediate drivers
NEXUSSURGL.BO stock led pre-market gainers with a +12.72% rise to INR 19.85 on Feb 2026. The stock opened at INR 17.33 and touched a day high of INR 19.99. Volume of 2,350.00 shares exceeded the average volume of 1,549.00, signaling short-term interest. Market participants cited stronger distribution demand in the medical supplies sector as the likely catalyst.
Fundamentals and valuation for Nexus Surgical & Medicare Ltd. on BSE
Nexus Surgical & Medicare Ltd. reported EPS of 0.97 and a trailing P/E around 19.20. Price to sales stands at 1.40 and price to book at 7.33. The company shows a current ratio of 2.45 and zero reported debt, supporting liquidity. These metrics point to modest profitability but rich book valuation versus peers.
Technical picture and trading levels for NEXUSSURGL.BO stock
Short-term indicators are neutral to mildly bullish. RSI sits at 53.89 and MACD shows a positive histogram of 0.07. ATR is 1.41, with Bollinger upper band at 19.33 and lower band at 16.06. Key support sits near the open at INR 17.33 and resistance near the year high at INR 22.00. Traders may watch a break above INR 20.00 for momentum continuation.
Meyka AI grade and model outlook for NEXUSSURGL.BO
Meyka AI rates NEXUSSURGL.BO with a score out of 100. Score: 68.76 | Grade: B | Suggestion: HOLD. This grade factors in S&P 500 comparison, sector performance, financial growth, key metrics, and analyst consensus. The grade balances strong return-on-equity metrics with high price-to-book and limited liquidity. Meyka AI’s analysis appears in our AI-powered market analysis platform context.
Price targets, forecast and risk-reward for Nexus Surgical BSE stock
Analyst-style targets place near-term resistance at INR 22.00 and initial support at INR 17.33. Conservative price target: INR 22.00; aggressive upside target: INR 26.00 on sustained momentum. Stop-loss consideration: INR 16.00. Investors should weigh limited average volume (1,549.00) and high PB at 7.33 as liquidity and valuation risks.
Sector context and catalysts affecting NEXUSSURGL.BO performance
Nexus Surgical operates in Healthcare, Medical – Distribution. The healthcare sector in India showed a modest 1-month gain and defensive flows in Feb 2026. Increased hospital procurement and medical consumable demand support distributors. However, sector peers trade at higher average PB and PE ratios, and broader investor appetite will influence NEXUSSURGL.BO stock momentum.
Final Thoughts
NEXUSSURGL.BO stock’s pre-market rally to INR 19.85 on Feb 2026 marked it among top gainers, driven by higher volumes and sector demand. Fundamentals show EPS 0.97, P/E around 19.20, and a clean balance sheet with current ratio 2.45. Technicals favour a test of INR 22.00; failure there leaves support at INR 17.33. Meyka AI’s forecast model projects a 1-year price near INR 16.21, implying a -18.33% gap versus the current price of INR 19.85. Forecasts are model-based projections and not guarantees. Traders should combine valuation, volume, and technical triggers before taking positions, and monitor news via the company site source and the issuer image profile source.
FAQs
What caused the NEXUSSURGL.BO stock rise in pre-market trading?
NEXUSSURGL.BO stock rose due to higher buying interest, an above-average volume of 2,350.00 shares, and sector demand for medical distribution supplies. Traders noted the strong open at INR 17.33 and momentum toward the year high of INR 22.00.
What are the key valuation metrics for Nexus Surgical (NEXUSSURGL.BO)?
NEXUSSURGL.BO shows EPS 0.97, trailing P/E roughly 19.20, price-to-sales 1.40, and price-to-book 7.33. The company reports no debt and a current ratio of 2.45, indicating liquidity but a rich book valuation.
How does Meyka AI view NEXUSSURGL.BO stock and its forecast?
Meyka AI rates NEXUSSURGL.BO with a score out of 100. Score 68.76 (Grade B, Suggestion HOLD). Meyka AI’s forecast model projects a 1-year price of INR 16.21, with model-based caveats and no guarantees.
What technical levels should traders watch for NEXUSSURGL.BO?
Traders should watch support at INR 17.33, resistance at INR 22.00, RSI 53.89, and Bollinger upper band 19.33. A daily close above INR 20.00 may signal continuation; failure below INR 17.33 raises downside risk.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.